1. Academic Validation
  2. Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf

Potent and selective inhibitors of PI3Kδ: obtaining isoform selectivity from the affinity pocket and tryptophan shelf

  • Bioorg Med Chem Lett. 2012 Jul 1;22(13):4296-302. doi: 10.1016/j.bmcl.2012.05.027.
Daniel P Sutherlin 1 Stewart Baker Angelina Bisconte Paul M Blaney Anthony Brown Bryan K Chan David Chantry Georgette Castanedo Paul DePledge Paul Goldsmith David M Goldstein Timothy Hancox Jasmit Kaur David Knowles Rama Kondru John Lesnick Matthew C Lucas Cristina Lewis Jeremy Murray Alan J Nadin Jim Nonomiya Jodie Pang Neil Pegg Steve Price Karin Reif Brian S Safina Laurent Salphati Steven Staben Eileen M Seward Stephen Shuttleworth Sukhjit Sohal Zachary K Sweeney Mark Ultsch Bohdan Waszkowycz Binqing Wei
Affiliations

Affiliation

  • 1 Genentech, Inc., 1 DNA Way, South San Francisco, CA 94080, USA. sutherd1@gene.com
Abstract

A potent inhibitor of PI3Kδ that is ≥ 200 fold selective for the remaining three Class I PI3K isoforms and additional kinases is described. The hypothesis for selectivity is illustrated through structure activity relationships and crystal structures of compounds bound to a K802T mutant of PI3Kγ. Pharmacokinetic data in rats and mice support the use of 3 as a useful tool compound to use for in vivo studies.

Figures
Products
我们的 Cookie 政策

我们使用 Cookies 和类似技术以提高网站的性能和提升您的浏览体验,部分功能也使用 Cookies 帮助我们更好地理解您的需求,为您提供相关的服务。 如果您有任何关于我们如何处理您个人信息的疑问,请阅读我们的《隐私声明》